Table 4 Performance of the three risk models in the validation group
Model | Score | No (%) | Death (%) | Median | P c |
|---|---|---|---|---|---|
Clinicopathological model | 0–2a | 12(30.0) | 3(25.0) | 38.0 |  |
3–7b | 28(70.0) | 19(67.9) | 24.5 | 0.003 | |
Total | 40 | 22(55.0) | 27.0 | Â | |
Molecular model | 0–2a | 20(50.0) | 9(45.0) | 30.5 |  |
3–5b | 20(50.0) | 13(65.0) | 24.0 | 0.032 | |
Total | 40 | 22(55.0) | 27.0 | Â | |
Model comprising molecular and clinicopathological factors | 0–6a | 19(47.5) | 6(31.6) | 30.6 |  |
7–12b | 21(52.5) | 16(76.2) | 25.0 | <0.001 | |
Total | 40 | 22(55.0) | 27.0 | Â |